Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Colorectal Cancer Diagnostic Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Diagnosis Type (Diagnostic Imaging, Stool Test, Biopsy, Others)
5.2.1.1. By Diagnostic Imaging (Sigmoidoscopy, Colonoscopy, and Others)
5.2.1.2. By Stool Test (Guaiac FOBT, Fecal immunochemical (or immunohistochemical) Test (FIT), FIT-DNA Test)
5.2.1.3. By Biopsy (Image Guided Biopsy, Liquid Biopsy, Others)
5.2.2. By Application (Hospitals & Specialty Clinics, Ambulatory Care Centers, and Others)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle-East and Africa)
5.2.4. By Company (2022)
5.3. Market Map
5.3.1. By Diagnosis Type
5.3.2. By Application
5.3.3. By Region
6. North America Colorectal Cancer Diagnostic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Diagnosis Type
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Colorectal Cancer Diagnostic Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Diagnosis Type
6.3.1.2.2. By Application
6.3.2. Canada Colorectal Cancer Diagnostic Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Diagnosis Type
6.3.2.2.2. By Application
6.3.3. Mexico Colorectal Cancer Diagnostic Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Diagnosis Type
6.3.3.2.2. By Application
7. Europe Colorectal Cancer Diagnostic Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Diagnosis Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Colorectal Cancer Diagnostic Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Diagnosis Type
7.3.1.2.2. By Application
7.3.2. France Colorectal Cancer Diagnostic Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Diagnosis Type
7.3.2.2.2. By Application
7.3.3. United Kingdom Colorectal Cancer Diagnostic Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Diagnosis Type
7.3.3.2.2. By Application
7.3.4. Italy Colorectal Cancer Diagnostic Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Diagnosis Type
7.3.4.2.2. By Application
7.3.5. Spain Colorectal Cancer Diagnostic Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Diagnosis Type
7.3.5.2.2. By Application
8. Asia-Pacific Colorectal Cancer Diagnostic Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Diagnosis Type
8.2.2. By Application
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Colorectal Cancer Diagnostic Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Diagnosis Type
8.3.1.2.2. By Application
8.3.2. Japan Colorectal Cancer Diagnostic Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Diagnosis Type
8.3.2.2.2. By Application
8.3.3. India Colorectal Cancer Diagnostic Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Diagnosis Type
8.3.3.2.2. By Application
8.3.4. South Korea Colorectal Cancer Diagnostic Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Diagnosis Type
8.3.4.2.2. By Application
8.3.5. Australia Colorectal Cancer Diagnostic Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Diagnosis Type
8.3.5.2.2. By Application
9. South America Colorectal Cancer Diagnostic Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Diagnosis Type
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Colorectal Cancer Diagnostic Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Diagnosis Type
9.3.1.2.2. By Application
9.3.2. Argentina Colorectal Cancer Diagnostic Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Diagnosis Type
9.3.2.2.2. By Application
9.3.3. Colombia Colorectal Cancer Diagnostic Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Diagnosis Type
9.3.3.2.2. By Application
10. Middle East and Africa Colorectal Cancer Diagnostic Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Diagnosis Type
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Colorectal Cancer Diagnostic Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Diagnosis Type
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Colorectal Cancer Diagnostic Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Diagnosis Type
10.3.2.2.2. By Application
10.3.3. South Africa Colorectal Cancer Diagnostic Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Diagnosis Type
10.3.3.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Clinical Trial Analysis
13.1. Ongoing Clinical Trials
13.2. Completed Clinical Trials
13.3. Terminated Clinical Trials
13.4. Breakdown of Pipeline, By Development Phase
13.5. Breakdown of Pipeline, By Status
13.6. Breakdown of Pipeline, By Study Application
13.7. Breakdown of Pipeline, By Region
13.8. Clinical Trials Heat Map
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (In Case of Listed Companies)
14.5. Key Personnel
14.5.1. Abbott Laboratories
14.5.2. Illumina, Inc.
14.5.3. Sysmex Corporation
14.5.4. Beckman Coulter
14.5.5. Siemens Healthineers AG
14.5.6. Quest Diagnostics
14.5.7. Danaher Corporation
14.5.8. Cancer Genetics Inc.
14.5.9. Biocept Inc.
14.5.10. Epigenomics AG
15. Strategic Recommendations
16. About Us and Disclaimer